Clinical Trials

400 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT02773485 2022-10-21

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

155 enrolled

Cholangiocarcinoma

NCT05519956 2022-09-19

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

398 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05164770 2021-12-21

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

160 enrolled

Lymphoid

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05097443 2021-11-19

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

130 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05035446 2021-10-11

Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer

120 enrolled

Surgery

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

356 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT03664869 2021-04-01

FB10

300 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT02381379 2020-09-14

MSIT

MyeloidOther hematologic neoplasm

118 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04533243 2020-08-31

Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

209 enrolled

Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive

NCT04351867 2020-07-16

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

196 enrolled

Stomach Neoplasms

NCT03264807 2020-03-03

Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer

518 enrolled

Stomach Neoplasms

NCT03788226 2019-10-16

A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

600 enrolled

Stomach Neoplasms

NCT00193739 2019-09-20

NACTcervix

635 enrolled

Uterine Cervical Neoplasms

NCT03978364 2019-06-07

A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC

MyeloidOther hematologic neoplasm

100 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03162276 2018-09-07

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

118 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT02455843 2017-09-19

Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC

275 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02896166 2017-06-14

Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03008109 2017-01-04

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02934685 2016-11-18

IG-VMAT for Localized Prostate Cancer

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT02957266 2016-11-15

CERVIPIB

400 enrolled

Uterine Cervical Neoplasms

NCT02865304 2016-08-12

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

80 enrolled

Breast Neoplasms

NCT02738346 2016-04-25

CBPC

164 enrolled

Small Cell Lung Carcinoma

NCT02144727 2016-04-20

ADDICT

1,880 enrolled

Gastric Adenocarcinoma

NCT00532194 2015-09-23

ICON6

486 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02255578 2014-10-02

EPCOS

50 enrolled

Polycystic Ovary Syndrome

NCT02024191 2013-12-31

GELUPO

80 enrolled

Peripheral Nervous System Diseases

NCT01849224 2013-07-16

Randomized Trial of Exercise on Lower Extremity Edema After Lymphadenectomy in Gynecologic Cancer

148 enrolled

Lymphedema, Motor Activity

NCT00517959 2012-12-11

SCRT

200 enrolled

CNS

Craniopharyngioma, Ependymoma, Meningioma

NCT00470951 2012-08-17

CTS-179

340 enrolled

Rectal Neoplasms

NCT01654146 2012-07-31

ICON8

1,485 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01501669 2012-07-18

PROCEED

222 enrolled

Breast Neoplasms

NCT01459328 2011-10-25

Resource-Sparing Curative Treatment for Rectal Cancer

350 enrolled

Rectal Neoplasms

NCT01452672 2011-10-17

Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer

600 enrolled

Breast Neoplasms

NCT00122746 2011-10-13

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

322 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT00896155 2011-08-30

CONSET

260 enrolled

Breast Neoplasms, Pulmonary Fibrosis

NCT00888797 2011-07-12

β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence

400 enrolled

Colorectal Neoplasms

NCT01214343 2011-06-15

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

190 enrolled

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT01373736 2011-06-15

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

CNSEndocrine

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Pheochromocytoma, Carcinoma, Medullary

NCT00452751 2010-09-21

KLASS

1,400 enrolled

Stomach Neoplasms

NCT00576914 2010-03-09

Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer

1,108 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01041833 2010-01-01

Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker

230 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00655421 2009-07-03

Oral Cancer Screening in Mumbai, India by Primary Health Care Workers

Head & NeckOther neoplasm

329 enrolled

Mouth Neoplasms, Precancerous Conditions, Tobacco Use

NCT00872352 2009-03-31

Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients

30 enrolled

Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

NCT00532818 2009-03-30

Hydralazine Valproate for Cervical Cancer

143 enrolled

Uterine Cervical Neoplasms

NCT00297570 2007-10-10

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

MyeloidOther hematologic neoplasm

90 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00533299 2007-09-21

Hydralazine Valproate for Ovarian Cancer

211 enrolled

Ovarian Neoplasms

NCT00486460 2007-06-14

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Pancreatic Neoplasms

NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

381 enrolled